Wanting Han

Yancheng Institute of Technology — China

Medicine · Health Sciences

13h-index783citations62works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(51), Epigenetics and DNA Methylation(17), Estrogen and related hormone effects(9), Cancer, Lipids, and Metabolism(8), Steroid Chemistry and Biochemistry(7)

Publications62 total

Enzyme Mimics of Bimetallic Nanoclusters for Detection of Trypsin
Journal of Analytical Chemistry·2026
Ag nanoclusters as nanozyme for detection of Hg2+ based on aggregation enhanced peroxidase-like activity
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy·2026
A Brief Analysis of the Characteristics of Interpretation Text of the Speech of Minister for Foreign Affairs of China at China-CELAC Forum
Scientific and Social Research·2025
Supplementary Data from LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
2025Open Access
Unified Optical Access Network: Architecture and Bandwidth Scheduling
2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Nature Genetics·2025· 1 citedOpen Access
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology
Journal of Clinical Investigation·2025Open Access
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer
2025Open Access
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
2025Open Access
Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
Data from LSD1 inhibition disrupts super-enhancer driven oncogenic transcriptional programs in castration-resistant prostate cancer
2024Open Access
Supplementary Data from LSD1 inhibition disrupts super-enhancer driven oncogenic transcriptional programs in castration-resistant prostate cancer
2024Open Access
Supplementary Data from LSD1 inhibition disrupts super-enhancer driven oncogenic transcriptional programs in castration-resistant prostate cancer
2024Open Access
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs
Journal of Clinical Investigation·2024· 31 citedOpen Access
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression
Cancer Research Communications·2023· 2 citedOpen Access
Abstract PR015: Inhibition of androgen receptor signaling in castrate resistant prostate cancer in association with inhibition of glycolysis by targeting hexokinase 2 activity with pyrrolopyrimidine-based small molecules
Cancer Research·2023
Abstract B004: Genomic loss of TP53 impairs AR-targeted activity in metastatic prostate cancer
Cancer Research·2023
Abstract A009: Distinct activity of androgen receptor splice variants in promoting prostate cancer metastasis
Cancer Research·2023
Supplementary Data from LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
2023Open Access
Supplementary Data from LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Changmeng Cai(43), Shuai Gao(30), Housheng Hansen He(26), Dong Han(25), Steven P. Balk(23), Jill A. Macoska(21), Muqing Li(19), Susan Patalano(17), Zifeng Wang(11), Musaddeque Ahmed(10), Mingyu Liu(10), Shuai Gao(10), Sujun Chen(9), Eva Corey(9), Junjie T. Hua(9), Elai Davicioni(9), Peter S. Nelson(9), Felix Y. Feng(8), Sen Chen(7), Fraser Soares(7)